Dhampur Bio Organics Limited has closed its trading window for dealing in company shares effective October 1, 2026. The restriction remains in force until 48 hours after the declaration of financial results for the quarter and half year ended September 30, 2026.

This action is taken pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015, read with the company's Code of Conduct for Regulating, Monitoring and Reporting of Trading by Insiders. The closure ensures compliance with regulatory standards regarding the handling of unpublished price-sensitive information.

Board meeting schedule

The date of the Board Meeting for the consideration of the aforementioned financial results will be intimated to the stock exchanges in due course. Until the results are declared and the specified cooling-off period elapses, insiders are prohibited from trading in the securities of the company.

Dhampur Bio Organics Limited’s promoter group entity, Sonitron Limited, acquired a total of 40,000 equity shares in two separate open market transactions during the first week of August 2026. The acquisitions, executed on August 05 and August 06, 2026, increased Sonitron’s aggregate holding to 1,15,20,499 shares, representing 17.353% of the company’s total share and voting capital. The disclosures were filed with the BSE Limited and the National Stock Exchange of India Limited under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

Two-Tranche Acquisition Details

Sonitron Limited, headquartered in New Delhi, conducted the purchases across two consecutive trading sessions. Mukul Sharma, Director of Sonitron Limited (DIN: 00078995), signed the disclosure forms dated August 06, 2026, from Mumbai. The first tranche involved the purchase of 25,000 equity shares on August 05, 2026, accounting for 0.038% of the total share capital. The second tranche saw the acquisition of 15,000 equity shares on August 06, 2026, representing 0.022% of the total share capital. Both transactions were carried out through the open market mechanism.

The following table outlines the movement in Sonitron Limited’s shareholding:

Capital Structure and Regulatory Compliance

The equity share capital of Dhampur Bio Organics remained constant at 6,63,87,590 equity shares of ₹10 each throughout both transactions. Consequently, the total diluted share/voting capital also remained unchanged at 6,63,87,590 equity shares. Sonitron Limited confirmed that none of the acquired shares are subject to encumbrance, pledge, lien, or non-disposal undertaking. Furthermore, there are no outstanding warrants or convertible securities held by the acquirer.

The disclosures comply with Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, which requires promoter group entities to report changes in shareholding upon crossing specified thresholds. Ashu Rawat, Company Secretary & Compliance Officer of Dhampur Bio Organics Limited, intimated the exchanges about the receipt of these disclosures on August 07, 2026.